TY - JOUR
T1 - Low levels of IgG recognizing the α-1-Antitrypsin peptide and its association with taiwanese women with primary sjögren’s syndrome
AU - Chang, Yu Sheng
AU - Pan, Chih Hong
AU - Chang, Che Chang
AU - Tsai, Kai Leun
AU - Chou, Han Wen
AU - Chen, Jin Hua
AU - Lin, Sheng Hong
AU - Lu, Yi Ying
AU - Tai, Chih Chun
AU - Lin, Yi Fang
AU - Lin, Ching Yu
N1 - Funding Information:
Acknowledgments: This study was supported by a grant (MOST104-2314-B-038-026) from the Ministry of Science and Technology, City, Taiwan. Proteomics data were analyzed by the Academia Sinica Common Mass Spectrometry Facilities on an LTQ-Orbitrap XL hybrid mass spectrometer located at the Institute of Biological Chemistry (Taipei, Taiwan). The authors thank Tzu-Yun Yu, Research Center of Biostatistics, College of Management of Taipei Medical University, Taiwan, who provided consultant services for power calculations.
Publisher Copyright:
© 2017 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2017/12/18
Y1 - 2017/12/18
N2 - The aim of this study was to examine oxidative stress and low level of α-1-antitrypsin (A1AT) in primary Sjögren’s syndrome (pSS), and evaluate the associated autoreactivity against unmodified and their 4-hydroxy-2-nonenal (HNE)-modified peptides with pSS. Two differentially expressed proteins, α-1-acid glycoprotein 1 (A1AG1) and A1AT, exhibited 2-fold differences, and their HNE modifications were identified by depleted-albumin and immunoglobulin G (IgG) serum protein, in-solution digestion, in-gel digestion, and nano-liquid chromatography-tandem mass spectrometry (nano-LC-MS/MS) from pSS patients and age-matched healthy controls (HCs). Furthermore, levels of proteins, confirmation of HNE modifications, HNE-protein adducts and autoreactivity against unmodified and their HNE-modified peptides were further validated. Levels of the HNE-protein adduct and A1AG1 were significantly higher in pSS patients than HCs, but levels of A1AT were significantly lower in pSS patients compared to HCs. Only the HNE modification of A1AT was confirmed. Our study suggests that elevated HNE-protein adduct, oxidative stress, level (odds ratio (OR) 4.877, p = 0.003), lowered A1AT level (OR 3.910, p = 0.010) and a decreased level of anti-A1AT50-63 IgG (OR 3.360, p = 0.010) showed an increased risk in pSS patients compared to HCs, respectively.
AB - The aim of this study was to examine oxidative stress and low level of α-1-antitrypsin (A1AT) in primary Sjögren’s syndrome (pSS), and evaluate the associated autoreactivity against unmodified and their 4-hydroxy-2-nonenal (HNE)-modified peptides with pSS. Two differentially expressed proteins, α-1-acid glycoprotein 1 (A1AG1) and A1AT, exhibited 2-fold differences, and their HNE modifications were identified by depleted-albumin and immunoglobulin G (IgG) serum protein, in-solution digestion, in-gel digestion, and nano-liquid chromatography-tandem mass spectrometry (nano-LC-MS/MS) from pSS patients and age-matched healthy controls (HCs). Furthermore, levels of proteins, confirmation of HNE modifications, HNE-protein adducts and autoreactivity against unmodified and their HNE-modified peptides were further validated. Levels of the HNE-protein adduct and A1AG1 were significantly higher in pSS patients than HCs, but levels of A1AT were significantly lower in pSS patients compared to HCs. Only the HNE modification of A1AT was confirmed. Our study suggests that elevated HNE-protein adduct, oxidative stress, level (odds ratio (OR) 4.877, p = 0.003), lowered A1AT level (OR 3.910, p = 0.010) and a decreased level of anti-A1AT50-63 IgG (OR 3.360, p = 0.010) showed an increased risk in pSS patients compared to HCs, respectively.
KW - 4-hydroxy-2-nonenal
KW - Autoantibody isotypes
KW - Inhibitor
KW - Primary Sjögren’s syndrome
KW - Serum
KW - α-1-antitrypsin
UR - http://www.scopus.com/inward/record.url?scp=85038428385&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038428385&partnerID=8YFLogxK
U2 - 10.3390/ijms18122750
DO - 10.3390/ijms18122750
M3 - Article
AN - SCOPUS:85038428385
SN - 1661-6596
VL - 18
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 12
M1 - 2750
ER -